Results 81 to 90 of about 17,213 (217)
Transcatheter Aortic Valve Replacement (TAVR) [PDF]
Transcatheter Aortic Valve Replacement Versus Surgical Aortic Valve Replacement in Treatment of Aortic Valve Stenosis Ashlee Blannett Faculty Mentor: Lorie Zelna, M.S., R.T.
Blannett, Ashlee
core +1 more source
ABSTRACT Background Preprocedural planning with multislice computed tomography (MSCT) is an essential prerequisite for successful transcatheter aortic valve replacement (TAVR). However, preprocedural planning is time‐consuming and may contain clinically meaningful interobserver variability.
Mark M. P. van den Dorpel +11 more
wiley +1 more source
In an independent multicenter cohort of 951 patients undergoing echocardiography, a deep learning model analyzing an 8‐s heart sound and ECG recording detected moderate‐or‐greater aortic stenosis with 92.9% sensitivity and 87.9% specificity. This approach may support the decision to refer patients from auscultation to echocardiography.
Shumpei Saito +23 more
wiley +1 more source
ABSTRACT Background Epicardial adipose tissue volume (EATV) is increasingly recognized as a cardiometabolic risk marker associated with adverse outcomes. The most established approach for EATV quantification is cardiac computed tomography (CT). MRI offers a radiation‐free alternative allowing simultaneous assessment of myocardial function and tissue ...
Judith Gronwald +10 more
wiley +1 more source
ABSTRACT Atrial fibrillation (AF) is closely associated with comorbidities and lifestyle factors that influence the development, progression, and outcomes. Here the focus is on guidelines for the systematic management of hypertension, heart failure, coronary and structural heart disease, diabetes, dyslipidemia, cerebrovascular disease, obesity, chronic
Eue‐Keun Choi +16 more
wiley +1 more source
Innovative Electrosurgery Application in the Era of TAVR-In-TAVR
[Figure: see text]
Leo Kar Lok Lai, Kent C.Y. So
openaire +2 more sources
LVAD‐associated aortic regurgitation impairs circulatory support, with limited surgical and off‐label options. In a multicenter registry (n = 30), the AR‐dedicated JenaValve Trilogy TAVR eliminated AR, achieving 96.7% (29/30) technical success and 93.3% (28/30) device success (VARC‐3), with 3.3% (1/30) 30‐day mortality.
Hristian Hinkov +13 more
wiley +1 more source
Transcatheter aortic valve replacement (TAVR) has become the standard treatment of multimorbid patients with severe aortic valve stenosis. One frequently observed complication after TAVR procedure is the occurence of paravalvular leakage (PVL).
Borowski Finja +6 more
doaj +1 more source
Commentary: TAVR-in-TAVR—Be a good host for your guest [PDF]
Siamak, Mohammadi +1 more
openaire +2 more sources
Valve-in-valve transcatheter aortic valve replacement (TAVR) leads to lower device success compared to TAVR in native stenosis [PDF]
BackgroundDespite the lack of randomized-controlled trials in patients with failed bioprosthetic valves, valve-in-valve transcatheter aortic valve replacement (ViV-TAVR) is increasingly used.MethodsOutcomes of consecutive patients treated with ViV-TAVR ...
Dominik Buckert +9 more
core +1 more source

